Week 96 data presented during a late-breaking oral session at EASL 2025 demonstrated the potential of EFX 50mg to reverse cirrhosis in high-need MASH subgroups, including patients with cryptogenic ...

Presented data highlights the potential of Annamycin for treating broad range of human cancers, including high-need oncology ...

More than half of all Americans drink alcohol—with 17 percent binge drinking, according to Centers for Disease Control and ...

Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, ...

This week, readers urge the government to support snooker as a sport in the city and warn against replacing professionals ...

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody ...

Delhi-NCR hospitals report a 40 per cent surge in hepatitis A and E cases this monsoon. Experts warn poor sanitation, unsafe ...

Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...

The event was preceded by a free liver health screening camp, which offered fasting blood sugar, lipid profile, liver ...

Trump teased the announcement, then Coca-Cola Co. confirmed it: a cane sugar-sweetened version of the beverage maker's trademark soda will be released in the U.S. this fall.

Even though fatty liver disease is often considered a silent disease since it usually does not cause symptoms until it becomes advanced, if ignored, it can also lead to various types of cancers.

Diagnosing liver cancer may have just gotten more straightforward, thanks to a new probe that makes the affected tissue glow yellow. The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow ...